Immunic (previously known as Vital Therapies) is a biopharmaceutical company. It develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.
Type | Public | |
Founded | 2003 | |
HQ | New York, NY, US | Map |
Website | immunic-therapeutics.com | |
Employee Ratings | More |
USD | |
---|---|
Net income (Q3, 2020) | (12.9m) |
EBIT (Q3, 2020) | (13.5m) |
Market capitalization (15-Jan-2021) | 370.7m |
Closing stock price (15-Jan-2021) | 17.9 |
Cash (30-Sept-2020) | 133.2m |
EV | 238.2m |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General and administrative expense | 2.7m | 2.5m | 2.6m | 3.1m | 3.5m | 2.7m | 2.8m | 2.7m | 2.8m | 3.1m | 2.7m | 3.0m | 4.3m | 4.3m | 2.5m | 2.7m | 9.0m | 2.1m | 2.6m | 2.2m | 2.5m |
R&D expense | 9.2m | 9.1m | 10.2m | 11.8m | 11.5m | 9.6m | 6.9m | 6.9m | 7.5m | 9.6m | 9.8m | 9.7m | 10.2m | 8.7m | 6.0m | 494.0k | 6.0m | 7.1m | 6.4m | 10.0m | 11.0m |
Operating expense total | 11.9m | 11.6m | 12.8m | 14.8m | 15.1m | 12.3m | 9.7m | 9.5m | 10.2m | 12.7m | 12.5m | 12.6m | 14.5m | 12.9m | 8.5m | 3.2m | 15.0m | 9.2m | 9.0m | 12.2m | 13.5m |
Depreciation and amortization | 24.0k |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 46.0m | 90.8m | 79.1m | 88.3m | 71.9m | 59.8m | 77.9m | 73.6m | 68.1m | 86.6m | 76.2m | 66.4m | 43.6m | 31.1m | 17.8m | 9.6m | 36.1m | 30.5m | 18.6m | 48.6m | 133.2m |
Prepaid Expenses | 1.3m | 1.4m | 1.6m | 828.0k | 2.1m | 1.8m | 1.0m | 1.6m | 1.4m | 1.7m | 1.9m | 1.6m | 1.2m | 1.5m | 1.3m | 393.0k | 2.5m | 4.1m | 5.0m | 4.4m | 4.4m |
Current Assets | 52.3m | 93.5m | 82.6m | 90.6m | 75.4m | 62.6m | 79.2m | 75.4m | 69.5m | 88.3m | 78.1m | 68.0m | 44.8m | 32.6m | 19.1m | 10.0m | 39.5m | 34.5m | 23.6m | 53.0m | 137.5m |
PP&E | 3.1m | 3.3m | 3.0m | 4.1m | 4.2m | 4.2m | 3.4m | 3.0m | 2.9m | 2.5m | 2.4m | 2.3m | 2.1m | 2.1m | 890.0k | 482.0k | 43.0k | 44.0k | 77.0k | 121.0k | 147.0k |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (10.7m) | (20.9m) | (33.7m) | (14.8m) | (29.9m) | (42.2m) | (9.6m) | (19.1m) | (29.2m) | (12.6m) | (25.0m) | (37.5m) | (14.4m) | (27.1m) | (39.0m) | (9.5m) | (19.0m) | (27.2m) | (8.5m) | (19.9m) | (32.9m) |
Depreciation and Amortization | 297.0k | 543.0k | 853.0k | 294.0k | 622.0k | 947.0k | 494.0k | 984.0k | 335.0k | 564.0k | 780.0k | 224.0k | 424.0k | 628.0k | 217.0k | 29.0k | 38.0k | 14.0k | 20.0k | 63.0k | |
Accounts Payable | (58.0k) | 337.0k | (142.0k) | 111.0k | (62.0k) | (397.0k) | (361.0k) | (360.0k) | (120.0k) | 396.0k | 46.0k | 211.0k | (145.0k) | 31.0k | 94.0k | (83.0k) | (1.4m) | 918.0k | (973.0k) | (676.0k) | 875.0k |
Cash From Operating Activities | (9.4m) | (19.2m) | (30.4m) | (13.5m) | (28.6m) | (40.7m) | (10.0m) | (18.8m) | (26.7m) | (10.9m) | (21.1m) | (30.5m) | (13.1m) | (25.4m) | (38.5m) | (3.7m) | (16.3m) | (22.3m) | (11.0m) | (20.3m) | (32.2m) |
USD | Q1, 2014 |
---|---|
Financial Leverage | -1 x |
Immunic has 314 Twitter Followers. The number of followers has increased 6.4% month over month and increased 11.4% quarter over quarter
434
Tweets
609
Following
314
Followers
24
Tweets last 30 days
1.6
Avg. likes per Tweet
100%
Tweets with engagement
When was Immunic founded?
Immunic was founded in 2003.
Who are Immunic key executives?
Immunic's key executives are Daniel Vitt, Duane Nash and Hella Kohlhof.
How many employees does Immunic have?
Immunic has 26 employees.
Who are Immunic competitors?
Competitors of Immunic include U.S. Stem Cell, Cannabis Sativa and Endologix.
Where is Immunic headquarters?
Immunic headquarters is located at 1200 6th Ave #200, New York.
Where are Immunic offices?
Immunic has offices in New York and Planegg.
How many offices does Immunic have?
Immunic has 2 offices.
Receive alerts for 300+ data fields across thousands of companies